Mallinckrodt Nellcor Puritan Bennett Line Breathes New Air Into Tyco
This article was originally published in The Gray Sheet
Executive Summary
Tyco International's decision to account for its $4.2 bil. stock acquisition of Mallinckrodt as a purchase rather than a pooling-of-interests transaction, gives the company the flexibility to divest Mallinckrodt's imaging drugs and bulk pharmaceuticals businesses and concentrate on the fast-growing respiratory products division.
You may also be interested in...
Tyco Urology Franchise Leaps Ahead With $3.2 Bil. Bard Acquisition
Tyco International will increase its total health care sales to about $7.6 bil. annually through acquisition of C.R. Bard for approximately $3.2 bil. in stock. Valued at nearly three times Bard's 2000 sales of $1.1 bil., the definitive agreement was announced May 30.
Tyco Urology Franchise Leaps Ahead With $3.2 Bil. Bard Acquisition
Tyco International will increase its total health care sales to about $7.6 bil. annually through acquisition of C.R. Bard for approximately $3.2 bil. in stock. Valued at nearly three times Bard's 2000 sales of $1.1 bil., the definitive agreement was announced May 30.
Tyco Takes Steps To Add InnerDyne Surgical Access Line Via $180 Mil. Bid
Tyco International's purchase of InnerDyne for $180 mil. would give the company access to the Sunnyvale, Calif. firm's Step line of minimally invasive access products for laparoscopic surgery.